EP4048278
Aðferðir til meðhöndlunar á illkynjunum í blóði með því að nota 2-(2,6-díoxópíperidín-3-ýl)-4-((2-flúor-4-((3-morfólínóasetidín-1-ýl)metýl)bensýl)amínó)ísóindólín-1,3-díón
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
20.10.2020EP published:
1.11.2023EP application number:
20807558.0
EP translation filed:
11.12.2023Grant published:
15.1.2024EPO information:
European Patent Register
Max expiry date:
19.10.2040Expiry date:
19.10.2026Next due date:
31.10.2026
Title in English:
METHODS OF TREATING HEMATOLOGICAL MALIGNANCIES USING 2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL)METHYL)BENZ YL)AMINO)ISOINDOLINE-1,3-DIONELanguage of the patent:
English
Timeline
Today
20.10.2020EP application
1.11.2023EP Publication
11.12.2023Translation submitted
15.1.2024Registration published
19.10.2026Expires
Owner
Name:
Celgene CorporationAddress:
86 Morris Avenue, Summit, NJ 07901, US
Inventor
Name:
ANTON, Maria Soraya, CarrancioAddress:
San Diego, CA 92121, US
Name:
BUCHHOLZ, Tonia J.Address:
San Francisco, CA 94185, US
Name:
KASIBHATLA, ShailajaAddress:
San Diego, CA 92121, US
Name:
LOPEZ-GIRONA, AntoniaAddress:
San Diego, CA 92121, US
Name:
NARLA, Rama, KrishnaAddress:
San Diego, CA 92121, US
Name:
POURDEHNAD, MichaelAddress:
San Francisco, CA 94185, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201962924028 PDate:
21.10.2019Country:
US
Classification
Categories:
A61K 31/5377, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 17.9.2024
Expires: 19.10.2025
Payer: Árnason Faktor ehf.
Number: 6
Paid: 10.10.2025
Expires: 19.10.2026
Payer: Árnason Faktor ehf.